Cargando…

The Economic Burden of Visceral Leishmaniasis in Sudan: An Assessment of Provider and Household Costs

Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated and is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL from the perspective of the provider and the household at three public hospitals in Gedaref State. The median to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meheus, Filip, Abuzaid, Abuzaid A., Baltussen, Rob, Younis, Brima M., Balasegaram, Manica, Khalil, Eltahir A. G., Boelaert, Marleen, Musa, Ahmed M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854893/ https://www.ncbi.nlm.nih.gov/pubmed/24189368 http://dx.doi.org/10.4269/ajtmh.12-0585

Ejemplares similares

The Household Costs of Visceral Leishmaniasis Care in South-eastern Nepal
por: Uranw, Surendra, et al.
Publicado: (2013)

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
por: Musa, Ahmed M., et al.
Publicado: (2010)

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
por: Omollo, Raymond, et al.
Publicado: (2011)

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
por: Meheus, Filip, et al.
Publicado: (2010)

Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
por: Khalil, Eltahir A. G., et al.
Publicado: (2014)

Single-dose liposomal amphotericin B (AmBisome(®)) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
por: Edwards, Tansy, et al.
Publicado: (2011)

The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis
por: Wasunna, Monique, et al.
Publicado: (2016)

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
por: Musa, Ahmed, et al.
Publicado: (2012)

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study
por: Dorlo, Thomas P C, et al.
Publicado: (2017)

Burden of Visceral Leishmaniasis in Villages of Eastern Gedaref State, Sudan: An Exhaustive Cross-Sectional Survey
por: Mueller, Yolanda Kathrin, et al.
Publicado: (2012)

Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan
por: Musa, A. M., et al.
Publicado: (2013)

An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani
por: Uranw, Surendra, et al.
Publicado: (2013)

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment
por: Adam, Abubakr O. A., et al.
Publicado: (2014)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
por: Younis, Brima M., et al.
Publicado: (2021)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
por: Wasunna, Monique, et al.
Publicado: (2016)

Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa
por: Verrest, Luka, et al.
Publicado: (2021)

Control of Visceral Leishmaniasis in Latin America—A Systematic Review
por: Romero, Gustavo A. S., et al.
Publicado: (2010)

Risk Factors of Inpatients Mortality of Visceral Leishmaniasis, Khartoum State, Sudan
por: Salih, Omaima Abdel Majeed Mohamed, et al.
Publicado: (2020)

Visceral leishmaniasis in Somalia: A review of epidemiology and access to care
por: Sunyoto, Temmy, et al.
Publicado: (2017)

Y Chromosome Lineage- and Village-Specific Genes on Chromosomes 1p22 and 6q27 Control Visceral Leishmaniasis in Sudan
por: Miller, E. Nancy, et al.
Publicado: (2007)

Case Report: Visceral Leishmaniasis with Salmonella Paratyphi and Brucella melitensis Coinfection as a Cause of Persistent Fever in a Patient from Sudan
por: El Safi, Sayda, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Epidemiology of Visceral Leishmaniasis in Algeria: An Update
por: Adel, Amel, et al.
Publicado: (2014)

Eliminating visceral leishmaniasis in South Asia: the road ahead
por: Rijal, Suman, et al.
Publicado: (2019)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
por: Singh, Om Prakash, et al.
Publicado: (2020)

Validation of Two Rapid Diagnostic Tests for Visceral Leishmaniasis in Kenya
por: Mbui, Jane, et al.
Publicado: (2013)

Epidemiology of visceral leishmaniasis among children in Gadarif hospital, eastern Sudan
por: Ahmed, Mohammed Ahmed A., et al.
Publicado: (2016)

“Kala-Azar is a Dishonest Disease”: Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
por: Boelaert, Marleen, et al.
Publicado: (2014)

Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010
por: Picado, Albert, et al.
Publicado: (2012)

Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control
por: Stauch, Anette, et al.
Publicado: (2011)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan
por: Nackers, Fabienne, et al.
Publicado: (2015)

Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?
por: el Harith, Abdallah, et al.
Publicado: (2019)

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
por: Verrest, Luka, et al.
Publicado: (2021)

Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview
por: Abuzaid, Abuzaid A., et al.
Publicado: (2017)

A clinical algorithm for triaging patients with significant lymphadenopathy in primary health care settings in Sudan
por: Khalil, Eltahir A.G., et al.
Publicado: (2013)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial
por: Musa, Ahmed M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_igf8bkdrkrrj9jh45kv3mf9m5q